Natural Capsules Intrinsic Value
Natural Capsules (NATCAPSUQ) median intrinsic value is ₹402.74 from 4 valuation models (range ₹81–₹470), vs current price ₹201.37 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit Natural Capsules share price screener.
NATCAPSUQ Valuation Methods Summary — DCF, Graham Number & P/E
Natural Capsules intrinsic value across 4 models vs current price ₹201.37 — upside/downside and value range per method. See NATCAPSUQ P/B ratio to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹470.00 | ₹423.00 - ₹517.00 | +133.4% | Book Value/Share: ₹235.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹402.74 | ₹362.47 - ₹443.01 | +100.0% | Revenue/Share: ₹236.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹80.55 | ₹72.50 - ₹88.61 | -60.0% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹102.12 | ₹81.70 - ₹122.54 | -49.3% | CF Growth: 5.0%, Discount: 15% |
NATCAPSUQ Intrinsic Value vs Market Price — All Valuation Models
Natural Capsules fair value range ₹81–₹470 vs current market price ₹201.37 across 4 valuation models. Check NATCAPSUQ company valuation to track the company's total market size over time.
NATCAPSUQ Intrinsic Value Analysis — Undervalued or Overvalued?
Natural Capsules median intrinsic value ₹402.74, current price ₹201.37 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of NATCAPSUQ?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Natural Capsules (NATCAPSUQ) is ₹402.74 (median value). With the current market price of ₹201.37, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹80.55 to ₹470.00, indicating ₹80.55 - ₹470.00.
Is NATCAPSUQ undervalued or overvalued?
Based on our multi-method analysis, Natural Capsules (NATCAPSUQ) appears to be trading below calculated value by approximately 100.0%.
NATCAPSUQ Financial Health — Key Ratios vs Industry Benchmarks
Natural Capsules financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -8.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
NATCAPSUQ Cash Flow Quality — Operating & Free Cash Flow
Natural Capsules operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹11 Cr | ₹6 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹27 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-8 Cr | ₹-45 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹17 Cr | ₹-36 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹-1 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |